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Abstract
Purpose—The purpose of this review is to identify emerging developmental toxicants that are 
understudied in children’s health. Exposures may arise from new products designed to improve 
utility, to reduce toxicity, or to replace undesirable chemicals. Exposures to less toxic chemicals 
may also be significant if they are very commonly used, thereby generating widespread exposure. 
Sources of exposure include the workplace, personal, home and office products; food, water, and 
air.
Recent Findings—We describe eight exposure categories that contain numerous potential 
developmental toxicants. References are discussed if reported in PubMed during the past decade at 
least ten-times more frequently than in 1990–2000. Examples included phthalates, phenols, 
sunscreens, pesticides, halogenated flame retardants, perfluoroalkyl coatings, nanoparticles, e-
cigarettes, and dietary polyphenols. Replacements are often close structural homologs of their 
precursors. We suggest biomonitoring as preferred means of exposure assessment to emerging 
chemicals. Some existing analytic methods would require minimal modification to measure these 
exposures, but others require toxicokinetic and analytic investigation.
Summary—A deliberate strategy for biomonitoring of emerging replacement chemicals is 
warranted, especially in view of concerns regarding developmental toxicity. To prevent adverse 
health effects, it is important to characterize such exposures before they become widely 
disseminated.
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Introduction
Emerging exposures are defined as environmental agents with potential for human exposure, 
where there is reason for concern about health effects. There may be limited toxicological 
and biomonitoring data but ample information on possible sources. Developmental toxicants 
may derive from parental occupational exposures, from use of personal or consumer 
products that contain toxic chemicals, or from contaminated food, water, or air. Estimating 
personal exposures to toxicants can sometimes be challenging in the absence of validated 
biomarkers. However, in some circumstances they may be reliably estimated by compiling a 
personal record of products utilized, foods consumed, or aspects of the home environment. 
Environmental exposure biomarkers are often desirable to quantify individual level exposure 
and monitor changes in exposure over time. As toxic, and, in particular, persistent, chemicals 
have been discovered in the environment, replacement materials have been developed by 
industry in response to consumer concerns or regulatory changes. Other new chemicals have 
arisen from modern technology. Some of these agents are suspected to be toxic, but are 
overlooked in research because there are no readily available exposure assessment and 
biomonitoring methods. This paper aims to identify emerging exposures and to suggest 
means of measuring them in people with a focus on organic chemicals.
Methods
We assembled in Table 1 a selected list of chemicals and products that are emerging 
toxicants, based on several kinds of use, including compounds that are being phased-out or 
replaced. We selected representative chemicals that are of increasing interest based on 
having been cited in the past ten years. We looked for existing analytic methods that could 
be used to detect these chemicals in the body with minimal modifications. We focus on this 
means of exposure assessment, as there are no comprehensive means of using retrospective 
recall of product use, diet, home environment, etc. that can capture sufficient information.
We searched for known, replacement, and other chemicals in PubMed during three 
timeframes: 1990–2000, the “past 10 years” (a PubMed option), using the terms including 
“chemical name”, “urine” and/or “exposure”, limited to humans. Items were included in 
Table 1 if citations in “past 10 years” were at least ten times more frequent than in 1990–
2000 and if they were also cited in the past two years. To compare with the overall rise in 
publications, a search for “exposure” alone found that the number of references doubled in 
the earlier vs later 10-yr periods (90,312 vs 185,167), and 35,385 references appeared for the 
past 2 years. Publications on “exposure and urine” increased about 1.5 times for the 10-yr 
intervals (4018 vs 6366), with 1340 in the past 2 years. This suggests that higher numbers 
for reported agents in Table 1 are not publication bias. Reference count changed over the 
months of assembling the information, and the Table enumeration is that retrieved on 
October 1, 2016. Not all references were reviewed individually, so some that do not directly 
address human exposure may be included in the count. We recognize that PubMed citations 
are lagged relative to the identification, measurement, and research on contaminants of 
concern; therefore, there is a need to identify additional exposures using knowledge of 
prevalent chemicals such as those in commonly used products [1].
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Results and Discussion
Table 1 lists selected potential emerging exposures in eight categories. Many of these 
chemicals occur together in products thus presenting exposure to a mixture of chemicals 
from their use [1]. Moreover, multiple chemicals also exist in many exposure sources, such 
as swimming pools (>40 chemicals including 14 UV filters) [2]. Many emerging exposures 
are close structural homologs of the replaced substance that were developed to reduce 
persistence and absorption in the body. However, replacement chemicals often do not 
represent an improvement in terms of health effects and may have substantial data gaps from 
which to estimate toxicity or population prevalence [3]. Almost all of these exposures are 
nonpersistent organic chemicals. It is remarkable that these exposures with citations before 
2000 are also those with reported health effects research.
Phthalates and phenols
Both phthalates and phenols have been associated with health outcomes in children, 
including neurodevelopment, allergy, and obesity [4,5,6]. For phthalates, health effects have 
been observed for exposures prenatally through childhood. Phthalates are used in a wide 
variety of consumer items including personal care products, food packaging, and building 
materials, resulting in widespread population exposure. More than 20 phthalate 
replacements have been reported [3]. Three of the newer ones have been found in human 
biomonitoring (DINCH, DEHT, DEHA; figure 1) [3,7]. It is unclear whether the 
replacements are less toxic or less persistent. Of some concern, brominated phthalates are 
being used as flame retardants [8].
Parabens are phenol preservatives that are extensively used in personal care products, food, 
and medications. Parabens are commonly detected in urine as the parent compound (largely 
conjugated). Newly identified specific oxidative metabolites may be more specific indicators 
of exposure than the parent compounds [9]. Triclosan and triclocarban have been banned 
recently for soaps, but still exist as biocides in many products [10]. 2,5-Dichlorophenol is 
the metabolite of 1,4-dichlorobenzene, a putative carcinogen used in mothballs and air and 
toilet fresheners; levels in the U.S. population are still considerable 10 years after the ban for 
use in schools [11]. bis-Phenol A (BPA) is a monomer found in dental sealants and food 
containers. It and several homologs have been measured in indoor environments and urine 
[12,13]. The BPA family of chemicals possesses strong estrogenic properties [14,15].
Existing analytic methods can be used to measure the phthalate monoester metabolites and 
many phenols in urine [16]. Urine is the preferred matrix, as phthalate and phenol 
metabolites are most highly concentrated there and there is less possibility of specimen 
contamination by extraneous sources. For nonyl phenol, there is not yet a valid method, as it 
is metabolized to multiple oxidative phenols [17].
Sunscreens (UV filters)
Sunscreens typically contain a mixture of 2–8 UV filtering agents, including multiple 
phenols (e.g. benzophenone-3 [BP3], avobenzene and paraben) as well as zinc oxide and 
titanium dioxide, the nanoparticle UV filters. While BP3, a phenol UV filter, has been 
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measured in many epidemiology studies, the others have not. They do not appear in Pub 
Med searches. Limited findings on development and somatic growth in children have been 
reported [18]. BP3, its analogs, and other chemicals from personal products are found in 
swimming pools and in the Pacific Ocean, where Hawaii has asked bathers not to use them 
in order to protect coral [19]. For many of the sunscreen ingredients, pharmacokinetic and 
metabolism information is needed to guide design of biomonitoring methods.
Other polyphenols including phytoestrogens
Phytoestrogens are natural polyphenols homologous molecularly to hormones and 
environmental phenols. They share biological activity with synthetic phenols, such as 
hormone antagonism and obesogenicity. They include isoflavones (soy), quercetin (fruits), 
and lignan metabolites (flax), and have long been considered as healthy micronutrients. 
Recently more than 80 phytoestrogens in urine were measured in a large European study, 
and in one report 4/37 urinary biomarkers had concentrations exceeding 10 um in urine [20]. 
Their dietary sources were mainly six foods [21].
Pesticides and herbicides
Pesticide residues such as DDE and the herbicide contaminant tetrachlorodibenzodioxin 
have declined steeply in recent decades in developed countries. For example, breast-milk 
DDE and PCBs in Sweden declined 10–20-fold over the past 30 years (Figure 2; [22]). 
Pesticides that replaced the persistent halogenated compounds, such as organophosphates, 
have also declined [11], but newer, less persistent pesticides are in use, with limited 
information on human exposure. Neonicotinoids have been measured in urine in a few 
human studies [23,24]. 2,4-Dichlorophenoxyacetic acid and glyphosate have also long been 
in continuous use as herbicides, with recent concerns about toxicity and carcinogenesis [25]. 
Urinary 2,4-dichlorophenoxyacetic acid levels increased from 1999–2010 in NHANES [16]. 
Glyphosate is the most commonly used pesticide in the United States, however, few methods 
exist to measure it in urine and those that do exist are extremely cumbersome. Newer 
methods should be developed to make the measurement of glyphosate more accessible and 
conducive to adding in other analytes for measurement. Another area of interest is the 
burgeoning use of thiazole fungicides where almost no studies have been done to understand 
toxicokinetics or exposure.
Halogenated Flame Retardants
PBDE flame retardants replaced molecularly homologous polybrominated biphenyls after a 
tragic accident contaminated cattle and the entire state of Michigan during 1974–76 [26]. 
PBDE levels began to increase world-wide (Figure 2), and newer replacements have come 
into being. While PBB and PBDE are persistent with half-lives in humans of 4–40 years, 
newer fire retardants are less persistent, and they have polar metabolites that can be detected 
in urine. These chemicals are also being controlled in the United States particularly in 
products used by children, such as sleeping mats [27]. Multiple halogenated 
organophosphates have been found in human biomonitoring studies, suggesting that they co-
occur in home items or are often used in items in the home [28].
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Perfluorinated Coatings
Perfluorinated alkyl carboxylic acids (PFCs) are used in oil and water resistant coatings for 
fabric and cookware, fire-retardant foam, and floor polish. Following the typical 
manufacturing practice, PFCs including PFOA and PFOS are being replaced with 
homologous longer chain chemicals. In Sweden and the US biomonitoring levels of PFOS 
have declined since 2000 after increasing in the 1990s (Figure 2). More than 20 replacement 
compounds have been reported, many with structures similar to PFCs [29]. It is not clear that 
these are less toxic or less persistent [30].
Nanoparticles
Nanomaterials are sub-micron sized fibers, tubes and large molecules made of metal, 
polymer, or carbon materials. They are controversial in terms of human exposure and 
toxicity, as it is contended that they are poorly absorbed from sunscreens and clothing [31]. 
However, they are also being applied as drug delivery systems including to the brain, 
suggesting that absorption or penetration is possible. Nanoparticles may be inhaled. Immune 
effects, inflammation, and possible developmental toxicity have been reported [31,32,33]. 
Validated methods for measuring nanoparticles in humans are limited to respiratory intake. 
However, limited literature suggests that they are absorbed, as they have been measured in 
body fluids, including Au-U [34]. Their disparate use makes use of recall methods almost 
impossible.
e-Cigarettes
Electronic- or e-cigarettes were introduced into the United States tobacco market in 2007; 
ever-use rapidly increased after 2010, especially among youth, to include 16% of high 
school students by 2015 [35]. The active ingredient in e-cigarette liquid is nicotine. E-
cigarette use results in nicotine urinary metabolites similar in level and pattern to those from 
users of tobacco and smokeless tobacco products. However, the oxidative nicotine 
metabolites are lower in users of e-cigarettes [36]. Diacetyl, 2,3-pentadione, and acetoin are 
structurally similar compounds that have been shown to cause bronchiolitis obliterans in 
exposed workers or laboratory animals [37]. They are also ubiquitous in fruity and sweet e-
liquid flavorings used in marketing to children, as well as in traditional tobacco flavorings 
such as menthol [38,39,40]. While these compounds are safe for ingestion, they cause lung 
toxicity when inhaled at concentrations likely to be generated by commercially available e-
cigarette liquids. Other flavor ingredients, that are “generally recognized as safe” (GRAS) to 
ingest by the Flavor and Extract Manufacturers Association (FEMA), and that are commonly 
added to food, have been identified by FEMA as potentially toxic to the lung, if inhaled 
[41,42]. There has been limited research to determine whether these aldehydes and other 
reactive flavorings are present in e-cigarette liquids. However, the implication by 
manufacturers that flavor ingredients used in e-cigarettes and related devices (e.g. hookahs) 
are safe for inhalation because they have FEMA GRAS™ status for use in food has been 
stated to be “false and misleading” by FEMA [43]. Unintentional nicotine poisoning of 
children as a result of e-cigarette liquid exposure has emerged recently as a public health 
problem [44, 45].
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Multiple and mixed exposures
Various chemicals we have described can occur in many different products, so that multiple 
exposures exist with everyday use. In NHANES exposure biomarker surveys, a large 
proportion of >250 measured chemicals are >50% detectable, meaning that many co-exist in 
the bodies of most people. Multiple sources of exposure exist; e.g., parabens might be 
absorbed from food, sunscreen, lotion, and lipstick. Plus, as noted above, many products 
contain more than one ingredient, which constitutes a mixture, so that users would be 
exposed to several chemicals at once (e.g. organic and nanoparticle UV filters with paraben 
in sunscreen). When 38,975 products were surveyed for developmental toxicant contents, 
30% had one or more chemical of interest and 1,059 contained three phenols [1].
Fundamental/Overarching needs
Before adequate biomonitoring methods can be developed for emerging chemicals, we need 
to conduct toxicological studies in animals or in silico to understand the toxicokinetics of 
these chemicals. It is imperative to know what metabolites are formed from non-persistent 
chemicals before we begin trying to monitor them in biological matrices. Experience, for 
example with high molecular weight phthalates, taught us that even similar chemicals in the 
same class may not metabolize similarly resulting in measurement of inappropriate or less 
useful biomarkers. In addition, one of the biggest challenges in methods’ development for 
emerging chemicals is the lack of authentic standards for measurement. It would be quite 
useful if industries introducing new chemicals into manufacture could conduct toxicokinetic 
studies to inform exposure scientists about potential biomarkers and to synthesize or isolate 
standards for the measurement of these biomarkers. Without metabolic information and 
standards, valid biomarker methods cannot be developed.
Conclusion
Many developmental toxicants can be determined using biomarkers. A number of these have 
been widely detected in the United States with levels rising in recent years [11]. Overall, 
however, attention has focused on a limited number of chemicals that have validated 
biomarkers or that have been most convenient to analyze. Historically, comprehensive health 
information has followed the discovery of widespread exposure, for example to lead, PCBs, 
and PFOA. We cited a number of exposures that have been introduced to replace or to 
improve other agents. Many products have more than one additive, and little is known about 
how mixtures or multiple chemicals interact. Biomonitoring or personal exposure 
assessment can characterize individual body burden more efficiently than information using 
recalled exposure sources.
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DDE 1,1′-dichloro-2,2′-bis(4-chlorophenyl)ethylene
PCBs polychlorinated biphenyls
PFOA/S perfluorooctanoic acid
PFOS perfluorooctanesulfonic acid
DINCH 1,2-cyclohexane dicarboxylic acid diisononyl ester
DEHT bis-(2-ethylhexyl)-terephthalate
DEHA bis-(2-ethylhexyl)-adipate
BPA bis-phenol A
NHANES National Health and Nutrition Examination Survey
PBDE polybrominated diphenyl ethers
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Key points
1. Biomonitoring of emerging exposures has often lagged peak population 
exposures, resulting in lapses of health risk assessment.
2. Agents without exposure monitoring also lack sufficient information on 
health effects.
3. Valid exposure biomarkers are not available for many well-known exposures 
of interest for child development.
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Figure 1. 
Phthalate urinary metabolites and long-chain replacements measured in the US (geometric 
means, all NHANES 1999–2012 [11]).
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Figure 2. 
Levels of POPs and PFOS in breastmilk in Sweden, data extracted from Fang et al., [22].
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Table 1
EMERGING EXPOSURES–Chemicals of concern with little human data, reported from 1/1/1990 – 
12/31/1999 and in the past 10 years.
Exposure Class Search terms # Citations, 1990–2000 # Citations, 
last 10 years
PHTHALATES AND PHENOLS
  Phthalate urine 14   449
  Phthalate replacements (long chain: decyl, nonyl, isononyl) urine   0     28
  DINCH (1,2-cyclohexane dicarboxylic acid diisononyl ester) exposure   1     16
  DEHT (bis-(2-ethylhexyl)-terephthalate) exposure   0       5
  DEHA (bis-(2-ethylhexyl)-adipate) exposure   0     10
  Bis Phenol A urine   9   399
  Bisphenol F, Bisphenol S urine   0     16
  Nonyl phenol exposure   1       6
  Parabens urine   1     84
  Triclosan, trichlocarban urine, exposure   9   143
  2,5-Dichlorophenol (2,4-dichlorobenzene metabolite) exposure   3     36
SUNSCREENS
  Benzophenone-3 or oxybenzone exposure   5     59
  Other terpenes (Limonene, citronella, linalool, mexoryl) exposure 22     68
  Avobenzene (Butyl methoxydibenzoylmethane, 
methoxydibenzoylmethane) b
exposure   2     13
POLYPHENOLS, including phytoestrogens urine 84   386
PESTICIDES
  Neonicotinoids urine, exposure   0     10
HALOGENATED FLAME RETARDANTS
 PBDE Exposure, plasma or 
serum
  4
  1
  445
  179
 TBBP-A exposure   0     12
 Hexabromocyclododecane exposure   0     96
 Brominated organophosphates exposure   1     13
 Brominated phthalates clusters (2-Ethylhexyl tetrabromobenzoate, 
bis(2-ethylhexyl) tetrabromophthalate)
exposure   0     13
 Chlorinated flame retardants exposure   3     59
COATINGS, PFOA REPLACEMENTS
  Long chain perfluoroalkyl acids exposure   1     14
  PFOA exposure   4   428
NANO PARTICLES OR NANOPARTICLES OR NANOPARTICLE exposure   0 2220
  Nano titanium, Zn, Ag, Au exposure   0   523
  Nano organics   0     60
e-CIGARETTES exposure   1   208
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Exposure Class Search terms # Citations, 1990–2000 # Citations, 
last 10 years
  e-cigarettes, Flavorings Exposure   0     11
  Nicotine, cotinine, e-cigarettes Urine   0     17
  Volatiles (acetoin/3-hydroxybutanone, diacetyl, pentanedione/
acetyl propionyl)
e-cigarettes   3     70
aSearch was done in October 2016, limited to Humans; items for these 2 intervals are listed if citations in “past 10 years” (a PubMed option) were 
ten times more frequent than in 1990–2000. Search parameters were as shown, e.g. “PFOA exposure”, limited to Humans, Limited to [date].
bAvobenzene included because of its potential wide exposure to humans, although the number of citations is slightly different than ten-times in past 
10 years.
Searched and not listed because recent references were too few (past ten or past two years): PAH, fuel additives, cotinine, Pb, Mn, Ti, PBB, PCB, 
DDT, DEET, nitrophenol, chlorpyrifos, pentachlorophenol, 2,4,5-TCP, 2,4-D, atrazine, DAPs, 4-t-octyl- and ortho-phenyl- phenols, 
benzophenone-2 or -4, octyl methoxycinnamate (octinoxate), homosalates (trimethylcyclohexenyl salicylate), octisalate (octyl salicylate), 
hydrofluoropolyether, perfluoroalkyl acids, perfluoroether carboxylic acids (PFECAs) and perfluoroether sulfonic acids (PFESAs including GenX 
— CF3CF2CF2OCF(CF3)COOH.NH3, Adona 3H-perfluoro-3-[(3-methoxy-propoxy)propanoic acid, ADONA, 3(4-methylbenzylidene)camphor 
(4-MBC), glyphosate
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